SIGA Technologies
SIGA
#8719
Rank
HK$1.74 B
Marketcap
HK$24.39
Share price
-1.27%
Change (1 day)
-56.00%
Change (1 year)

SIGA Technologies (SIGA) - Total liabilities

Total liabilities on the balance sheet as of March 2026 : HK$0.53 Billion

According to SIGA Technologies's latest financial reports the company's total liabilities are HK$0.53 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

SIGA Technologies - Total liabilities on balance sheet (from 2001 to 2026)

Total liabilities by year

Year Total liabilities Change
2025-12-31HK$0.16 B-27.48%
2024-12-31HK$0.22 B-50.67%
2023-12-31HK$0.44 B131.03%
2022-12-31HK$0.19 B-38.32%
2021-12-31HK$0.31 B102.86%
2020-12-31HK$0.15 B-80.21%
2019-12-31HK$0.78 B-0.3%
2018-12-31HK$0.78 B-78.46%
2017-12-31HK$3.65 B5.11%
2016-12-31HK$3.47 B-4.58%
2015-12-31HK$3.64 B15.37%
2014-12-31HK$3.15 B130.33%
2013-12-31HK$1.37 B128.01%
2012-12-31HK$0.60 B56.09%
2011-12-31HK$0.38 B230.9%
2010-12-31HK$0.11 B-19.96%
2009-12-31HK$0.14 B159.93%
2008-12-31HK$55.96 M33.91%
2007-12-31HK$41.79 M-20.34%
2006-12-31HK$52.46 M135.45%
2005-12-31HK$22.28 M84.83%
2004-12-31HK$12.05 M183.7%
2003-12-31HK$4.24 M-17.05%
2002-12-31HK$5.12 M-1.38%
2001-12-31HK$5.19 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Sarepta Therapeutics
SRPT
HK$13.12 B 2,370.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
HK$9.31 B 1,652.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
HK$0.43 B-18.80%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
HK$8.35 M-98.43%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
HK$7.98 B 1,403.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
HK$6.25 B 1,076.54%๐Ÿ‡บ๐Ÿ‡ธ USA